The tweet was deleted by the author.
But we saved everything 🙂.
Definium Therapeutics announced it will report its first quarter 2026 financial results and business updates during a live webcast scheduled for 4:30 p.m. EST on May 7, 2026.
The company has invited interested parties to review details and register for the event through its latest press release. Investors and analysts tracking $DFTX will be watching for new insights into the firm's performance and outlook.
Definium Therapeutics previously hosted an Investor and Analyst Day in New York City to update on its progress in psychedelic treatment development. The event provided details on the company's ongoing research initiatives. Investors and analysts are likely to consider these earlier updates alongside the forthcoming financial results.